At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Switzerland based CFO’ operating in the Health Care space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected].
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Fernando Cunha
CFO of AB2 Bio
Follow Fernando Cunha:
About AB2 Bio: AB2 Bio is a drug discovery and development company.
Valentin Matillon
SVP – Chief Financial Officer of SOPHiA GENETICS
Valentin Matillon joined SOPHiA GENETICS in 2018 as Chief Financial Officer. He is a seasoned finance executive with over 20 years of leadership experience in IT, Telecommunications and MedTech companies. He has held a number of senior finance management positions at SITA, Electronic Arts and Hewlett-Packard, including Group CFO, senior finance director in charge of corporate finance, financial planning & analysis, and performance management programs. Most recently, as senior finance director at the Hobart Group, Valentin led the corporate finance, financing & accounting operations team. As CFO, Valentin focuses on increasing shareholder value by driving global financial excellence and long-term sustainability. In addition to leading the Finance organization, Valentin is also in charge of the Legal department and Business Development activities. He received his Finance B.A. from Institut des Hautes Etudes Economiques et Commerciales de Paris and his MS from Ecole Centrale de Paris, France. “It is not the strongest of the species that survives, but the most adaptable” – Charles Darwin
Follow Valentin Matillon:
About NOVIGENIX, SOPHiA GENETICS: SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.
Urs Breitenstein
CFO of Strekin
URS BREITENSTEIN CHIEF FINANCE OFFICER Dr. Urs Breitenstein supports companies and investors with his corporate transactions, financing or valuation expertise and with his network. As a partner of Hoffmann & Co AG, a Swiss M&A and CFO services company, he is involved with several startups and growth companies in the life science sector as interim or part time CFO, as business advisor or as a board As a board member, he also represents an investment company. Urs previously served for more than ten years as a team leader and partner at international professional service firms (PwC, Deloitte) providing valuation, corporate finance and M&A services. He supported many large and mid-sized life science (but also manufacturing and service sector) transactions in Switzerland and in Europe. He is a graduate of the postgraduate study centre of the Swiss National Bank at Gerzensee and holds a doctorate in economics from the University of Basel.
Follow Urs Breitenstein:
About Hoffmann & partner, Kinarus AG, Strekin, Versameb: Strekin AG is a clinical-stage biopharmaceutical company headquartered in Basel, Switzerland.
Max Sieghold
Co-Founder & CFO of Sleepiz
Follow Max Sieghold:
About Sleepiz: Sleepiz is a Zürich based startup with the aim to enable the medical community to take healthcare into the home environment.
André C Muller
EVP, Chief Financial Officer of Idorsia
Follow André C Muller:
About Idorsia: The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients.
Robin Berger
Chief Financial Officer of KetoSwiss
Robin Berger is the Chief Financial Officer at KetoSwiss.
Follow Robin Berger:
About KetoSwiss: KetoSwiss is a Swiss-based BioTech startup that strives to bring ketone bodies back into the modern world to combat diseases.
Robin Berger
Chief Financial Officer of KetoSwiss
Robin Berger is the Chief Financial Officer at KetoSwiss.
Follow Robin Berger:
About KetoSwiss: KetoSwiss is a Swiss-based BioTech startup that strives to bring ketone bodies back into the modern world to combat diseases.
Martin de Groot
Chief Financial Officer of Xeltis
Follow Martin de Groot:
About Xeltis: Xeltis is a clinical-stage medical device company leveraging breakthrough science to transform heart valve therapy.
Christophe Guichard
Chief Businesss Officer, CFO and Board Member of NETRIS Pharma
Follow Christophe Guichard:
About ArisGen, Eclosion SA, NETRIS Pharma: NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the pharmaceutical industry.
Paul R Hofer
Founder, CEO & CFO of Hutman Diagnostics
Since graduating with a Master of Economics from the University of Basel, Switzerland in 1972, Paul focused on building his Financial and business management career. During this time he spent extensive and successful years at the Credit Suisse Group working on various high level and international assignments.
Follow Paul R Hofer:
About Hutman Diagnostics: Hutman Diagnostics is an in vitro diagnostics product development and portfolio management company.
Jonathan Campbell
Co-Founder, COO and CFO of hystrix medical
Follow Jonathan Campbell:
About hystrix medical: hystrix medical is a online contracting marketplace for medical devices and replenishing / repeat purchase products in hospitals.
David Magaw
CFO of Swiss Medendi
Follow David Magaw:
About Swiss Medendi: Swiss Medendi is a medical device company in Lugano, Switzerland.
Reto Suter
CFO of Siegfried Holding
Reto Suter serves as the Chief Financial Officer of the Siegfried Group.
Follow Reto Suter:
About Siegfried Holding: Siegfried Holding is a pharmaceutical company that offers and manufactures primary and secondary drug substances and products.
Stéphane Velan
CFO, Co-founder of Pristem
Swiss, born in 1961, graduated with a degree in business management, Master of Science in Management from HEC University in Lausanne and PED program in international management at IMD, Stéphane has more than 20 years’ Management & Operational experience and expertise and has held senior executive positions (Chairman, Board member/President du Directoire and CEO) for more than 10 years in numerous Swiss and international companies, in various activities, with different types of shareholders/investors. Stephane has an impressive track record in Business building & Management (incl. Luxury & Watches, telecommunication, high-tech start-ups, Strategic Project), in Finance (M&A, Investment funds, Venture Capital, Equity fundraising, structured finance, financial engineering, portfolio management, credits & risks, tax optimisation), and Consulting (strategy, Business development, operational, production, marketing & sales). He has led multidisciplinary operational teams of experts, has managed large budgets and many large teams throughout his career. Founder member of the Foundation Essentialmed, Stephane has actively participated to the definition of the strategy of the Foundation and to the concept of developing and deploying effective, high-quality and affordable medical devices, adapted to the needs of impoverished communities across the globe. He has notably been part of the first concrete project named “GlobalDiagnostiX” developped and fully supported by EPFL, Lausanne, that became Pristem SA. Stéphane founded in 2010 the Swiss Watch Company Frères Rochat SA, specialised in the Singing Bird automatons, which he sold in 2016.
Follow Stéphane Velan:
About Pristem: Pristem is a swiss medtech company providing robust, cost-effective, easy and safe medical systems, designed for primary health care.